SkyView Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-748
| Closed | -$263K | – | 760 |
|
|
2023
Q2 | $263K | Sell |
748
-1,318
| -64% | -$463K | 0.07% | 336 |
|
|
2023
Q1 | $651K | Buy |
2,066
+708
| +52% | +$223K | 0.15% | 175 |
|
|
2022
Q4 | $392K | Sell |
1,358
-712
| -34% | -$206K | 0.12% | 239 |
|
|
2022
Q3 | $599K | Buy |
2,070
+364
| +21% | +$105K | 0.18% | 190 |
|
|
2022
Q2 | $481K | Buy |
1,706
+376
| +28% | +$106K | 0.13% | 243 |
|
|
2022
Q1 | $347K | Sell |
1,330
-14,920
| -92% | -$3.89M | 0.08% | 320 |
|
|
2021
Q4 | $269K | Buy |
+16,250
| New | +$269K | 0.06% | 356 |
|
|
2021
Q1 | – | Sell |
-1,303
| Closed | -$308K | – | 322 |
|
|
2020
Q4 | $308K | Buy |
+1,303
| New | +$308K | 0.15% | 152 |
|